Asia-Pacific Myocardial Infarction Market Growth, Share & Forecast 2020-2026

By | July 28, 2020

Asia-Pacific myocardial infarction market is estimated to grow at the fastest CAGR of around 7.3% during the forecast period. Increasing cases related to CVD and heart attack, increasing healthcare infrastructure, and increasing unhealthy lifestyles among people in the region are some of the major factors for the growth of the market in Asia-Pacific. Moreover, increasing medical tourism and improving healthcare infrastructure are also contributing significantly to the growth of the myocardial infarction market in the region. The region provides future opportunities for growth as the demand for myocardial infarction treatment is continuously increasing in emerging economies such as India and China due to increasing cardiovascular disorders. According to the WHO, CVD causes one-third of the total fatalities each year in China. The rising geriatric population and associated prevalence of the chronic disease in them continue to spur the demand for myocardial infarction diagnosis and treatment.

Please read the originial post here: https://www.omrglobal.com/industry-reports/asia-pacific-myocardial-infarction-market

Author: lareb khan

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.